Inhibrx Biosciences Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Inhibrx Biosciences Inc had 161.66M in cash and cash equivalents.

Inhibrx Biosciences Inc reported 138.49M in total liabilities as of the latest reported quarter, including 33.80M in current liabilities and 104.69M in non-current liabilities.

As of the latest reported quarter, Inhibrx Biosciences Inc's total assets were 146.48M, consisting of 132.83M in current assets and 13.65M in non-current assets.

Inhibrx Biosciences Inc reported 7.99M in total shareholders' equity as of the latest reported quarter.